Partners and customers
Iscaffpharma provides a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer
Partner with us!
Iscaffpharma will partner with pharmaceutical companies based on co-development and license agreements. We will:
- License and sell synthetic scaffolds, with the possibility of support for analyses
- Offer verification of 3D results in human scaffolds
- Offer target and drug screening
In addition, we will develop our own cancer drug portfolio based on the platform. Our main Focus is on solid cancer:
- Breast
- Colon
- Ovarian
- Orphan
- Moving in to other forms
Iscaffpharma will seek partnerships for commercialization of NCEs from our own portfolio.
We will develop our technology as a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer.
Contact contact@iscaffpharma.com for more information
Partners
